Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

Bibliographic Details
Main Authors:	Donskov, Frede, Michaelson, M Dror, Puzanov, Igor, Davis, Mellar P, Bjarnason, Georg A, Motzer, Robert J, Goldstein, David, Lin, Xun, Cohen, Darrel P, Wiltshire, Robin, Rini, Brian I
Format:	Online
Language:	English
Published:	Nature Publishing Group 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705883/

Similar Items

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma
by: Cella, David, et al.
Published: (2014)

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
by: DePrimo, Samuel E, et al.
Published: (2007)

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
by: Rini, Brian I., et al.
Published: (2011)

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
by: Cella, D, et al.
Published: (2012)

Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib
by: Molina, Ana M., et al.
Published: (2010)

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma
by: Harmon, Charles S., et al.
Published: (2013)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
by: Hutson, T E, et al.
Published: (2014)

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α
by: Patil, S, et al.
Published: (2012)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
by: Motzer, R J, et al.
Published: (2013)

Metastatic collecting duct carcinoma of the kidney treated with sunitinib
by: Tazi, El Mehdi, et al.
Published: (2011)

A Case of Metastatic Adamantinoma That Responded Well to Sunitinib
by: Liman, Andrew D., et al.
Published: (2016)

Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
by: de Wit, Djoeke, et al.
Published: (2014)

Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
by: Ordu, Çetin, et al.
Published: (2016)

Combining targeted and immunotherapy: BRAF inhibitor dabrafenib (D) ± the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation-positive unresectable or metastatic melanoma (MM)
by: Puzanov, Igor
Published: (2015)

Drug Management of Visceral Pain: Concepts from Basic Research
by: Davis, Mellar P.
Published: (2012)

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
by: Molina, Ana M., et al.
Published: (2013)

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
by: Gore, M E, et al.
Published: (2015)

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment
by: Chara, Luis, et al.
Published: (2011)

Retraction: metastatic collecting duct carcinoma of the kidney treated with Sunitinib
by: Tazi, El Mehdi, et al.
Published: (2011)

Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma
by: Wei, Guoqing, et al.
Published: (2012)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
by: Gilabert, M, et al.
Published: (2013)

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
by: Morizane, Shuichi, et al.
Published: (2012)

Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
by: Yildiz, Ibrahim, et al.
Published: (2014)

Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma
by: Voss, Martin H, et al.
Published: (2016)

Terbinafine and Neutropenia
by: Yavaşoğlu, İrfan
Published: (2015)

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
by: Diekstra, Meta H. M., et al.
Published: (2015)

Continuing a Cancer Treatment Despite Tumor Growth May Be Valuable: Sunitinib in Renal Cell Carcinoma as Example
by: Burotto, Mauricio, et al.
Published: (2014)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
by: Doaa Naeem, et al.
Published: (2018-08-01)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
by: Hashiguchi, Yasunori, et al.
Published: (2015)

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial
by: Jun Guo, et al.
Published: (2018-05-01)

Primary and secondary autoimmune neutropenia
by: Capsoni, Franco, et al.
Published: (2005)

Developments in the management of febrile neutropenia
by: Pascoe, J
Published: (2011)

Fluoxetine-induced neutropenia
by: Bavle, A.
Published: (2012)

Third molar pericoronitis in neutropenia
by: Kano Fumiya, et al.

Ipilimumab-Induced Neutropenia in Melanoma
by: Ban-Hoefen, Makiko, et al.
Published: (2016)

Sunitinib: the antiangiogenic effects and beyond
by: Hao, Zhonglin, et al.
Published: (2016)

Sunitinib Induced Immune Thrombocytopenia
by: Shekarriz, Ramin, et al.
Published: (2015)

Olanzapine-Induced Neutropenia
by: Malhotra, Kirti, et al.
Published: (2015)

A case of feverish neutropenia
by: Invernizzi, Rosangela, et al.
Published: (2014)

Sepsis and neutropenia in hematological malignancies
by: Labiad, Y, et al.
Published: (2014)